ScholarIQanswers from OpenAlex & ORCID
Jennifer A. Wargo
ResearcherPublications, citations & collaboration network
Jennifer A. Wargo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jennifer A. Wargo have?
ScholarIQindexed works
Jennifer A. Wargo has 1,509 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jennifer A. Wargo have?
ScholarIQcitation count
Jennifer A. Wargo has 89,241 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jennifer A. Wargo?
ScholarIQh-index
Jennifer A. Wargo has an h-index of 127 in OpenAlex.
What is the i10-index of Jennifer A. Wargo?
ScholarIQi10-index
Jennifer A. Wargo has an i10-index of 322 in OpenAlex.
What is the ORCID of Jennifer A. Wargo?
ScholarIQorcid
The ORCID for Jennifer A. Wargo is on the source record.
What is the OpenAlex record for Jennifer A. Wargo?
ScholarIQopenalex
The OpenAlex for Jennifer A. Wargo is on the source record.
What are the most-cited papers on Jennifer A. Wargo?
ScholarIQmost cited works
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur, Keren Yizhak, Moshe Sade-Feldman, Jorge Blando, Guangchun Han, Vancheswaran Gopalakrishnan, Yuanxin Xi, Hao Zhao, Rodabe Navroze Amaria, Hussein Tawbi, Alexandria P. Cogdill, Wenbin Liu, Valerie S. LeBleu, Fernanda G. Kugeratski, Sapna P. Patel, Michael A. Davies, Patrick Hwu, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Reetakshi Arora, Scott E. Woodman, Emily Z. Keung, Pierre-Olivier Gaudreau, Alexandre Reuben, Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks, Nancy Gavert, Yaara Zwang, Leore T. Geller, Aviva Rotter-Maskowitz, Roi Weiser, Giuseppe Mallel, Elinor Gigi, Arnon Meltser, Gavin M. Douglas, Iris Kamer, Vancheswaran Gopalakrishnan, Tali Dadosh, Smadar Levin‐Zaidman, Sofia Avnet, Tehila Atlan, Zachary A. Cooper, Reetakshi Arora, Alexandria P. Cogdill, Md Abdul Wadud Khan, Gabriel O Ologun, Yuval Bussi, Adina Weinberger, Maya Lotan‐Pompan, Ofra Golani, Gili Perry, Merav Rokah, Keren Bahar‐Shany, Elisa A. Rozeman, Christian U. Blank, Anat Ronai, Ron Shaoul, Amnon Amit, Tatiana Dorfman, Ran Kremer, Zvi R. Cohen, Sagi Harnof, Tali Siegal, Einav Yehuda‐Shnaidman, Einav Nili Gal‐Yam, Hagit Shapira, Nicola Baldini, Morgan G. I. Langille, Alon Ben‐Nun, Bella Kaufman, Aviram Nissan, Talia Golan, Maya Dadiani, Keren Levanon, Jair Bar, Shlomit Yust‐Katz, Iris Barshack, Daniel S. Peeper, Dan J. Raz, Eran Segal, Jennifer A. Wargo, Judith Sandbank, Noam Shental, Ravid Straussman
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, John P. Ray, Carl G. de Boer, Russell W. Jenkins, David Lieb, Jonathan Chen, Dennie T. Frederick, Michal Barzily-Rokni, Samuel S. Freeman, Alexandre Reuben, Paul Hoover, Alexandra–Chloé Villani, Elena V. Ivanova, Andrew Portell, Patrick H. Lizotte, Amir Reza Aref, Jean-Pierre Eliane, Marc R. Hammond, Hans Vitzthum, Shauna Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, Zachary A. Cooper, Cloud P. Paweletz, David A. Barbie, Anat Stemmer‐Rachamimov, Keith T. Flaherty, Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller, Michal Barzily-Rokni, Tal Danino, Oliver Jonas, Noam Shental, Deborah Nejman, Nancy Gavert, Yaara Zwang, Zachary A. Cooper, Kevin Shee, Christoph A. Thaiss, Alexandre Reuben, Jonathan Livny, Roi Avraham, Dennie T. Frederick, Matteo Ligorio, Kelly Chatman, Stephen Johnston, Carrie M. Mosher, Alexander Brandis, Garold Fuks, Candice R. Gurbatri, Vancheswaran Gopalakrishnan, Michael P. Kim, Mark W. Hurd, Matthew H. G. Katz, Jason B. Fleming, Anirban Maitra, David A. Smith, Matt Skalak, Jeffrey Bu, Monia Michaud, Sunia A. Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T. Flaherty, Anna Mandinova, Wendy S. Garrett, Sarah P. Thayer, Cristina R. Ferrone, Curtis Huttenhower, Sangeeta N. Bhatia, Dirk Gevers, Jennifer A. Wargo, Todd R. Golub, Ravid Straussman
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel, Rona Ortenberg, Adi Lahat, Lior H. Katz, Katerina Adler, Daniela Dick‐Necula, Stephen Raskin, Naamah Bloch, Д. Л. Ротин, Liat Anafi, Camila Avivi, Jenny Melnichenko, Yael Steinberg‐Silman, Ronac Mamtani, Hagit Harati, Nethanel Asher, Ronnie Shapira‐Frommer, Tal Brosh‐Nissimov, Yael Eshet, Shira Ben-Simon, Ziv Oren, Md Abdul Wadud Khan, Moran Amit, Nadim J. Ajami, Iris Barshack, Jacob Schachter, Jennifer A. Wargo, Omry Koren, Gal Markel, Ben Boursi